Efficacy, immunogenicity and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomized controlled trial - Zhu, Feng‐Cai; Chen, Wen; Hu, Yue‐Mei; Hong, Ying; Li, Juan; Zhang, Xun; Zhang, Yi‐Ju; Pan, Qin‐Jing; Zhao, Fang‐Hui; Yu, Jia‐Xi; Zhang, Yan‐Shu; Yang, Xiaoping; et al. (International journal of cancer, 2014)
Keywords: Adolescent; Adult; Cancer; Cervical cancer; Cervical Intraepithelial Neoplasia - immunology; Cervical Intraepithelial Neoplasia - prevention & control; Cervical Intraepithelial Neoplasia - virology; Cervix; China; Clinical outcomes; DNA, Viral - genetics; Double-Blind Method; efficacy; Female; Follow-Up Studies; Human papillomavirus; Human papillomavirus 16 - isolation & purification; Human papillomavirus 18 - isolation & purification; human papillomavirus vaccine; Humans; Immunization; Immunogenicity; Infectious Causes of Cancer; Medical research; Neoplasm Grading; Papillomavirus Infections - immunology; Papillomavirus Infections - prevention & control; Papillomavirus Infections - virology; Papillomavirus Vaccines - therapeutic use; Polymerase Chain Reaction; Safety; Treatment Outcome; Uterine Cervical Dysplasia - immunology; Uterine Cervical Dysplasia - prevention & control; Uterine Cervical Dysplasia - virology; Uterine Cervical Neoplasms - immunology; Uterine Cervical Neoplasms - prevention & control; Uterine Cervical Neoplasms - virology; Vaccination; Vaccine efficacy; Vaccines; Young Adult; China; human papillomavirus vaccine; China; safety; efficacy; immunogenicity